We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+13.16%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$14.9B
AUM Growth
+$995M
Cap. Flow
-$291M
Cap. Flow %
-1.95%
Top 10 Hldgs %
26.38%
Holding
2,856
New
31
Increased
336
Reduced
1,500
Closed
71

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$28.4M
2
MSFT icon
Microsoft
MSFT
+$25.6M
3
NVDA icon
NVIDIA
NVDA
+$15.2M
4
AMZN icon
Amazon
AMZN
+$11.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 27.53%
2 Financials 12.17%
3 Healthcare 11.68%
4 Consumer Discretionary 10.99%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VUZI icon
2826
Vuzix
VUZI
$218M
-31,911
Closed -$66.5K
WW
2827
DELISTED
WW International
WW
-29,241
Closed -$256K
PAMT
2828
PAMT Corp
PAMT
$279M
-3,579
Closed -$74.4K
VOXX
2829
DELISTED
VOXX International Corporation Class A
VOXX
-6,433
Closed -$68.7K
SBT
2830
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
-11,706
Closed -$67.5K
MOND
2831
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
-24,620
Closed -$68K
VTNR
2832
DELISTED
Vertex Energy, Inc
VTNR
-35,713
Closed -$121K
BIG
2833
DELISTED
Big Lots, Inc.
BIG
-16,782
Closed -$131K
PGTI
2834
DELISTED
PGT, Inc.
PGTI
-29,892
Closed -$1.22M
FSR
2835
DELISTED
Fisker Inc.
FSR
-104,527
Closed -$183K
CBAY
2836
DELISTED
Cymabay Therapeutics
CBAY
-59,442
Closed -$1.4M
AYX
2837
DELISTED
Alteryx Inc
AYX
-3,712
Closed -$175K
KRTX
2838
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-2,000
Closed -$633K
SPLK
2839
DELISTED
Splunk Inc
SPLK
-9,432
Closed -$1.44M
TGH
2840
DELISTED
Textainer Group Holdings limited
TGH
-21,105
Closed -$1.04M
SOVO
2841
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
-29,370
Closed -$647K
MDRX
2842
DELISTED
Veradigm Inc. Common Stock
MDRX
-59,347
Closed -$623K
ROVR
2843
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
-52,840
Closed -$575K
RYZB
2844
DELISTED
RayzeBio, Inc. Common Stock
RYZB
-10,892
Closed -$677K
ICVX
2845
DELISTED
Icosavax, Inc. Common Stock
ICVX
-15,059
Closed -$237K
IMGN
2846
DELISTED
Immunogen Inc
IMGN
-125,461
Closed -$3.72M
NVTA
2847
DELISTED
Invitae Corporation
NVTA
-125,769
Closed -$78.8K
TSP
2848
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
-84,682
Closed -$74.3K
ESMT
2849
DELISTED
EngageSmart, Inc.
ESMT
-25,965
Closed -$595K
MRTX
2850
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-1,064
Closed -$62.5K

Similar funds

MetLife Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, MetLife Investment Management held 2,856 positions worth $14.9B, up 7.2% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.6%. MetLife Investment Management opened 31 new positions and exited 71, leaving the 2,856-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q1 2024 buy was Flutter Entertainment: 9,898 shares worth $1.98M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $128M increase.
  • MetLife Investment Management's biggest Q1 2024 reduction was Apple, cutting an estimated $28.4M.
  • MetLife Investment Management fully exited Immunogen Inc in Q1 2024, selling an estimated $3.72M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $14.9B portfolio in Q1 2024.
  • MetLife Investment Management opened 31 new positions and closed 71 in Q1 2024.
  • MetLife Investment Management's portfolio value rose 7.2% quarter-over-quarter to $14.9B.

Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.